Trial
NCT00406172
Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Asociación para Evitar la Ceguera en México
Collaborators
—
Condition
Cystoid Macular Edema
Intervention
Bevacizumab
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-05